MAPT and Alzheimer disease: Whereas dephosphorylation was observed for every other epitope over 120 min, we observed a substantial increase in phosphorylation at the 12E8 site, an ‘early AD marker’ antibody raised against ‘KXGS’ motifs in the MTBD of human tau [1], [14] (Fig. 1).